Authorization

Nikkei hits 1-month high on coronavirus vaccine hopes

Tokyo shares rose Wednesday, sending the benchmark Nikkei to a one-month high, as reports about progress in the development of a novel coronavirus vaccine by a U.S. company helped ease market concern about the pandemic.
The 225-issue Nikkei Stock Average ended up 358.49 points, or 1.59 percent, from Tuesday at 22,945.50, its highest close since June 10. The broader Topix index of all First Section issues on the Tokyo Stock Exchange finished 24.36 points, or 1.56 percent, higher at 1,589.51.
All industrial categories advanced, led by mining, steel and iron, and machinery issues.


KYODO
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«     2020    »
 12
3456789
10111213141516
17181920212223
24252627282930
31